Accendra Health, Inc. ACH

0.71 (0.02) (2.74%) as of 25 Sep
Market cap
$59.2M
P/E
0.0×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
9,723.43 9,318.28 9,418.19 9,210.94 8,480.18 9,785.32 9,955.48 2,552.57 2,680.11 2,762.03
Revenue Growth
(0.51%) (4.17%) 1.07% (2.20%) (7.93%) 15.39% 1.74% (74.36%) 5.00% 3.06%
Cost of Revenue
8,536.12 8,146.41 8,347.67 8,082.45 7,199.34 8,272.09 8,129.12 1,335.55 1,399.73 1,472.73
Gross Profit
1,187.31 1,171.87 1,070.53 1,128.49 1,280.83 1,513.23 1,826.35 1,217.02 1,280.38 1,289.30
SG&A Expenses
970.42 1,016.98 952.87 1,023.07 1,041.34 1,077.06 1,554.82 1,001.66 1,082.34 1,067.56
Operating Income
199.60 89.25 (352.35) 73.15 204.12 368.47 142.91 133.23 (217.73) 27.46
Non-operating Income/Expense
(27.06) (31.77) (74.75) (101.87) (94.21) (91.72) (132.02) (117.97) (112.15) (129.41)
Non-operating Interest Expenses
27.06 31.77 70.98 98.11 83.40 48.09 128.89 116.77 107.57 107.18
EBT
172.54 57.48 (427.09) (28.72) 109.91 276.75 10.89 15.27 (329.88) (101.95)
Income Tax Provision
63.76 (15.31) (32.43) (6.13) 21.83 55.17 (11.50) 6.36 20.85 0.73
Income after Tax
108.79 72.79 (394.66) (22.58) 88.07 221.59 22.39 8.91 (350.73) (102.68)
Dividends (Preferred)
1.15 1.06 0.00 — 0.00 0.00 — 0.00 0.00 —
Net Income Common
107.64 71.73 (437.01) (62.37) 29.87 221.59 22.39 (41.30) (362.69) (1,100.64)
EPS (Basic)
1.76 1.20 (7.28) (1.03) 0.47 3.05 0.30 (0.54) (4.73) (14.31)
EPS (Diluted)
1.76 1.20 (7.28) (1.03) 0.47 2.94 0.29 (0.54) (4.73) (14.31)
Shares (Basic, Weighted)
61.09 60.00 60.01 60.57 63.37 72.74 74.50 75.79 76.74 76.90
Shares (Diluted, Weighted)
61.09 60.00 60.01 60.57 63.51 75.49 76.22 77.37 76.74 76.90
Gross Margin
12.21% 12.58% 11.37% 12.25% 15.10% 15.46% 18.35% 47.68% 47.77% 46.68%
EBIT Margin
2.05% 0.96% (3.74%) 0.79% 2.41% 3.77% 1.44% 5.22% (8.12%) 0.99%
EBT margin
1.77% 0.62% (4.53%) (0.31%) 1.30% 2.83% 0.11% 0.60% (12.31%) (3.69%)
Net Profit Margin
1.11% 0.77% (4.64%) (0.68%) 0.35% 2.26% 0.22% (1.62%) (13.53%) (39.85%)
Free Cash Flow Margin
1.68% 0.07% 0.55% 1.24% 3.30% 0.76% 2.08% 24.83% 1.82% (8.15%)
EBITDA
254.99 148.69 189.19 189.83 297.45 459.09 371.58 343.60 270.66 241.98
EBIT
199.60 89.25 (352.35) 73.15 204.12 368.47 142.91 133.23 (217.73) 27.46
Income from Continuous Operations
108.79 72.79 (394.66) (22.58) 88.07 221.59 22.39 8.91 (350.73) (102.68)
Income from Discontinued Operations
— — (42.35) (39.79) (58.20) — — (50.21) (11.95) (997.96)
Consolidated Net Income/Loss
108.79 72.79 (437.01) (62.37) 29.87 221.59 22.39 (41.30) (362.69) (1,100.64)
EPS (Basic, from Continuous Ops)
1.78 1.21 (6.58) (0.37) 1.39 3.05 0.30 0.12 (4.57) (1.34)
EPS (Basic, from Discontinued Ops)
— — (0.70) (0.66) (0.92) — — (0.66) (0.16) (12.97)
EPS (Basic, Consolidated)
1.78 1.21 (7.28) (1.03) 0.47 3.05 0.30 (0.54) (4.73) (14.31)
EPS (Diluted, from Cont. Ops)
1.78 1.21 (6.58) (0.37) 1.39 2.94 0.29 0.12 (4.57) (1.34)
EPS (Diluted, from Disc. Ops)
— — 0.00 0.00 0.00 — — 0.00 0.00 0.00
Shares (Diluted, Average)
61.09 60.00 60.01 60.57 63.51 75.49 76.22 75.79 76.74 76.90
EPS (Diluted, Consolidated)
1.78 1.21 (7.28) (1.03) 0.47 2.94 0.29 (0.53) (4.73) (14.31)
EBITDA Margin
2.62% 1.60% 2.01% 2.06% 3.51% 4.69% 3.73% 13.46% 10.10% 8.76%
Operating Cash Flow Margin
1.93% 0.61% 1.23% 1.80% 4.00% 1.27% 3.26% 29.02% 6.03% (3.69%)

Fold the line items

In millions of $ except per-share values · columns are period end dates